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Objective To assess the validity and reliability of the 
ICSmale questionnaire developed for the International
Reliability was assessed by measures of internal con­
sistency and a test-retest analysis.
Continence Society-Benign Prostatic Hyperplasia’ Results The ICSmale questionnaire was easy to complete. 
(ICS-’BPH*) study. It was clearly able to differentiate between men in
clinical and community populations, and detected the 
expected positive age gradient for most symptoms in
«
the community group. There was reasonable agree­
ment between relevant parts of the questionnaire and 
frequency-volume charts when a relatively flexible 
approach was taken, but there was a very poor 
relationship between questions assessing strength of 
stream and the results of urollowmetry. Internal con­
sistency was high, and overall the questionnaire dem­
onstrated good test-retest reliability.
Patients and methods Urology departments in 12 coun­
tries recruited 1271 consecutive men > 4 5  years old, 
with lower urinary tract symptoms and possible 
benign prostatic obstruction, to the ICS-’BPH’ study 
(the clinical group); 423  ambulent men were recruited 
from a general practice in the UK to provide a com­
munity group. Each individual was asked to complete 
the wide-ranging ICS male questionnaire, comprising 
questions concerned with urinary symptoms, the 
bother they cause, and issues of quality of life and
sexual function. Content, construct and criterion val- Conclusion The self-completed questionnaire
idity of the symptom and problem questions were had high levels of psychometric validity and reliability.
assessed by interviews with patients and urologists, Keywords Benign prostatic hyperplasia, urinary symp- 
testing hypotheses within sub-studies, and in rela- toms, questionnaire, 
tion to frequency-volume diaries and urollowmetry.
Introduction
There are currently at least six questionnaires available 
to researchers
3). In one half of these,benign prostatic enlargement 
bladder outlet obstruction (BOO) results, termed benign 
prostatic obstruction (BPO). Thus, the original name of
the study has been reti 
commas and the terms delined
; use of i
appropriate.
of the ICS-BPH’ s t \ O
the results of high 
range of urinary
to measure levels of urinary 
symptoms in middle-aged and elderly men. The style 
and process of the development of these questionnaires 
has changed markedly in the .18 years since the first 
was published, although their major aim, of measuring 
urinary symptoms quantitatively, has not. A further 
questionnaire, which is the focus of this paper, is cur­
rently under development within the ICS-BPH* study.
The title of this study is now somewhat misplaced, as 
views on the use of the term BPH have changed and are which contains a wide range of urinary symptoms. It is 
changing rapidly [1]. BPH is an histological term and, intended that this questionnaire is developed so that it 
as a disease process, affects 70% of men >  70 years old may be used in research and clinical practice. This paper 
[2]. In some patients, the gland enlarges and is termed focuses on the validity and reliability of the
quality urodynamic studies and a
>. Existing questionnaires measure only a Uni­
toof symptoms, and so it was
a new
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questionnaire acci 
psycho me trie tes Li n g .
to standard me of
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The current range o f published symptom  scores
The symptom scores derived from questionnaires cur-
associated with the lower urinary tract, including ques­
tions related to various types of incontinence.
rently available for use in clinical studies of men with 
urinary symptoms are: Boyarsky [3] and Madsen-Iversen Method of completion
[4], the Maine Medical Assessment Program (MMAP) There are several important differences in how the
instrument [5], the Danish symptom score (DAN-PSS-1) questionnaires are completed among the scoring systems.
[6], the AUA symptom score [7], the I-PSS (which The Boyarsky [3] and Madsen-Iversen [4] questionnaires
is advocated for use by the WHO International were designed to be completed by clinicians. The MMAP
Consultation on BPH [8] and an adapted version of the instrument [5], DAN-PSS-1 [6], AUA symptom score [7],
Boyarsky schedule, the Bolognese instrument [9].
Selection of sym ptom s
the I-PSS [8] and the Bolognese instrument [9], are all 
intended to be completed by patients. Self-completion
questionnaires have several advantages over those com­
pleted by the clinician. They are likely to more accurately
Many different symptoms are included in the various represent the patient’s perception rather than the clin-
questionnaires and the process of selecting symptoms ician’s interpretation of particular symptoms. They also
has varied considerably and has been largely arbitrary. make it easier for patients to report the prevalence and
No other questionnaire includes all possible urinary severity of embarrassing symptoms. The ICSmale ques-
symptoms. The Boyarsky group claimed that ‘BPH is a tionnaire has been designed to be completed by the
familiar and clear-cut concept ... the symptoms are patient.
clear’. [3]. Madsen and Iversen claimed that they
included symptoms which were ‘frequent complaints in 
patients’. [4]. The MMAP designed their questionnaire 
after discussion with urologists.[5]. The DAN-PSS-1 listed
Inclusion of a ‘bother’factor
A new concept was introduced in the DAN-PSS-1 system;
‘known symptoms of hyperplasia’. [6]. With the AUA before 1991, symptom scores focused only upon the
score, symptoms were chosen from a ‘list compiled by presence and severity of a symptom. DAN-PSS-1 intro-
members of the AUA Measurement Committee’, and 
were subjected to psychometric testing [71. None of these
duced the concept of the ‘bother’ factor, i.e. the degree 
of a problem or bother that each symptom caused [6].
scores has been validated against an objective diagnosis The AUA questionnaire also includes a set of seven
of BOO using urodynamic techniques. ‘bother’ questions, corresponding to its symptom ques-
Little evidence exists to suggest which individual symp tions, although these are entirely separate.
toms are related to BPH, BPE or BPO and there is no In the ICSmale questionnaire, each question concern-
clear concept of which groups of symptoms should be ing the prevalence and degree of occurrence of a urinary
used to identify or measure patients with these conditions symptom is followed immediately by a question asking
[8,10,11]. Interestingly, is only one symptom about the degree of problem that it causes. This allows
which is included in all six of the scores noted above men to consider their experience of each symptom and
(frequency), although live other symptoms are shared then identify with some precision how much it bothers
by live of the six scores (weak stream, incomplete empty- them, with responses ranging from ‘no problem’,
ing, hesitancy, nocturia and intermittency). There are through ‘a bit of a problem’ and ‘quite a problem’, to ‘a
ilso several other symptoms which are included in one serious problem.’
or more scores (dysuria, terminal dribble, straining,
urgency, post-micturition dribble and incontinence of 
various sorts).
The developmental version of the ICSmale questionnaire
Quality of life and sexual junction
Measurements of quality of life and sexual function are
contains 20 symptom questions. These were devised based receiving increasing attention and have been important
on the symptoms in questionnaires, symptoms
raised by men referred to urology clinics who participated 
in in-depth interviews at the commencement of the study,
factors within the ICS-BPH’ study. The ICSmde ques­
tionnaire contains a number of questions associated with 
quality of life and sexual function, details of which will
and several other symptoms identified by urologists to be be published elsewhere.
associated with lower urinary tract functioning. Thus,
the ICS male questionnaire contains symptoms associated 
with the storage phase, previously called ‘irritative’ symp­
toms, and the voiding phase, previously called ‘obstruc­
tive’ symptoms, as well as a range of other symptoms
Patients and methods
In the ICS-BPH’ study, 1271 consecutive men >45  
years of age, attending urology departments in 12
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countries, with symptoms and possible BPO were the UK were invited to complete the ICSmale question-
recruited between January 1992 and December 1994. naire (for details, see [10]).
which relates to how well theMen with significant urological disease (e.g. prostate (iii) Criterion
cancer), neurological disease, with previous prostatic questionnaire correlates with a ‘gold standard’ measure
surgery, or taking medication active on the lower urinary (clinical or other validated instruments). The ‘gold stan-
tract, were excluded. dard’ for the measurement of BOO is pressure-ilow
Each patient was asked to complete a frequency- studies (pQS). The ICSmale questionnaire was tested in 
volume chart, detailing the times of urination during relation to the results of high quality pQS, and these 
the day and night over a period of one week. Each also results will be reported elsewhere. Within the ICS—‘BPH’
completed the ICS male questionnaire, which contains 22 study it is also possible to compare the results from
questions measuring 20 urinary symptoms, with 19 also frequency-volume diaries kept by patients against par- 
assessing the degree of problem that they cause, as well ticular items in the questionnaire (frequency, nocturia), 
as seven condition-specific quality-of-life questions and In addition, the validity of questions associated with the 
four items concerning sexual functioning (for further strength of stream was assessed in relation to the maxi­
details of the questionnaire, contact the authors). The mum flow rate achieved during 
questionnaire was developed in English and then pro- Correspondence between the frequency-volume diaries 
fessionally translated into 10 other languages. Each and the responses to the questionnaire was investigated
translation was then re-translated and checked by a lay using both crude percentage agreements following suit-
advisor or senior urologist from each country who was able coding, and a chance-corrected measure of agree
nominated as a national co-ordinator for the ICS-'BPH’ ment, the Kappa statistic [18].
study . Men in the UK also completed the UK version of
the SF-36 [12] and EuroQol [13], covering generic health 
issues, the results of which will be reported elsewhere.
As part of the study, all men were asked to void into 
a uroflowmeter on three occasions. The highest maxi-
Reliability of the ICSmale questionnaire
The reliability of a questionnaire refers to its ability to 
be consistent, stable and reproducible. Internal consist-
mum flow rate (Qmax) was used for the purposes of the
analyses presented here.
ency was measured by statistical procedures, e.g. 
Cronbach’s alpha, which assesses the interrelationships
of items within the questionnaire [19]. A test-retest
Validity and reliability
It is important that questionnaires exhibit good validity
analysis was carried out to assess the reliability of the 
questionnaire, in particular the stability of responses to 
questions over time. Clearly, a questionnaire which
and reliability. The ICS male questionnaire was tested for cannot demonstrate that its questions provoke stable
a range of types of validity: responses over a short period of time in a pre-treatment
(i) Content validity which tests whether the items in the sample will not be able to measure accurately changes
questionnaire measure what they are supposed to meas after treatment. A sub-group of 40 patients in two UK
ure. It is important that questions are understandable centres was contacted by post and asked to complete a
and unambiguous to the patient. In addition, the ques- further ICS male questionnaire at home within 2 weeks
tions must be clinically sensible. These aspects were of their first questionnaire. These data have been ana-
assessed through interviews with patients, by measuring lysed graphically and using i ses of paired differences,
levels of missing data (an indicator of inappropriate 
questions), and discussions with urologists.
rather than correlations i 
represent agreement [20].
which do not adequately
(ii) Construct validity which relates to the relationships
between the questionnaire and underlying theories. For 
example, there is a generally reported increase in urinary 
symptom scores, and some individual symptoms, with Table 1 Indicates the numbers of men recruited from each
increasing age in men in the general population [14-17] 
and the questionnaire should be able to reflect this.
country to 
men was 66
have lower levels of urinary symptoms than years. The c
‘BPH’ study. The mean age of the
2
Similarly, it is anticipated that men in the community (43%) aged 60-69
(21%) < 6 0  years, 512 
434 (36%) aged > 7 0 
distribution in the com-
attending urology clinics. Thus, the distribution of symp- munity sample was 63%), 22% and 14%, respectively [10’
toms across age-groups within the ICS-'BPH ’ study is 
reported, with the results of a sub-study of a population- 
based group of men in which all ambulent men, aged
The content validity was high; 1256 patients com- 
the ICSmale questionnaire, with the vast majority
. For individual symptoms,(94%) so uni
40 years, registered with a rural general practice in missing data were very rare (1% to 5%).
© 1996 British journal of Urology 77, 554-562
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Table 1 Numbers of patients recruited from each country to the
ICS-BPH’ study
Country
Number of 
patients
Australia 47
Canada 35
Denmark 121
Germany 129
Israel 10
Italy 58
J apan 105
Netherlands 391
Portugal 49
Sweden 73
Taiwan 39
UK 214
Total 1271
Construct validity
Table 2 details the prevalences of individual symptoms 
reported by the patients in the ICS-BPH’ study and by 
a sample of men in the community, according to the 
age of the patient. As anticipated, men in the com­
munity reported lower levels of symptoms than patients
in a clinical setting. Table 2 also shows that there was 
a general increase in the prevalence of the majority of 
symptoms with increasing age in the community 
sample, although this did not always reach statistical 
significance. The two sets of P-values in Table 2 are 
difficult to compare absolutely as the two sample sizes 
are very different; the age gradient needs to be much 
greater in the community sample to reach the same 
level of statistical significance as in the ICS-BPH’ 
patients. Hesitancy and dysuria have a negative but 
insignificant relationship with age in the community 
sample. Frequency (according to question 1: number of 
times per day) and the symptoms of straining to 
continue, incomplete emptying, post-micturition dribble, 
and nocturnal incontinence are similar in prevalence 
across the age groups.
In the ICS-BPH’ patients, the pattern was different 
(Table 2). Here, the general pattern of a positive 
association with age is not evident, except for the 
symptoms of nocturia and urge incontinence. On the 
whole, there were high prevalences of symptoms in all 
age groups with a general tendency to a negative 
association with age.
Table 2 Prevalence (%) of symptoms in the 
ICS male questionnaire by age for the 
patients in the ICS-’BPH’ study and for a 
community sample, with tests of 
significance across the age groups for each 
of the samples separately
IIM^I
ICS-BPH’patients (a = 1 2 5 6 ) Community sample (n= 4 2 3 )
Symptom
< 6 0
years
6 0 - 6 9  7 0 +  
years years
P-
value
< 6 0
years
6 0 - 6 9  7 0 +  
years years
P-
value
Terminal dribble 96 94 91 0.018 79 78 73 0.63
Hesitancy 90 85 79 <0.001 53 47 49 0.61
Intermittency 90 90 84 0.018 44 53 53 0.22
Urgency 67 76 77 0.007 44 51 64 0.025
Post micturition dribble 69 69 65 0.30 44 40 42 0.83
Weak stream (words) 94 94 93 0.81 30 37 52 0.006
Weak stream (diagram) 87 89 88 0.72 21 53 60 0.003
Incomplete emptying 82 83 77 0.047 32 35 34 0.83
Frequency (hours) 71 70 69 0.83 29 43 34 0.049
Repeated urination 73 76 64 <0.001 24 28 27 0.71
Strain to continue 77 71 63 0.001 23 22 25 0.91
Urge incontinence 36 46 56 <0.001 13 26 41 < 0 .001
Dysuria 45 44 38 0.087 22 15 13 0.14
Strain to start 74 61 57 0.001 18 17 12 0.50
Bladder pain 48 43 35 0.001 15 14 19 0.70
Nocturia 66 74 79 <0.001 7 15 43 < 0 .001
Frequency (times) 51 48 43 0.10 11 15 12 0.58
Stress incontinence 12 14 18 0.088 8 14 14 0.16
Always weak stream 40 46 45 0.39 6 9 10 0.42
Mise incontinence 16 20 22 0.14 4 9 12 0.057
Sitting to urinate 21 19 17 0.50 2 2 5 0.46
Acute retention 8 10 12 0.43 1 3 8 0.0026
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Criterion validity
very reduced, to 1 indicating a ‘normal’ flow). Clearly, 
neither of these questions allowed a direct comparison
Within with the flow rates recorded on uroflowmetry. However,
responses to questions concerning frequency and noctu- it was possible to determine whether men with a low
ria with details from the frequency-volume diaries kept flow rate recorded a reduced stream on questions 12
by patients over one week. Similarly, questions concern- and 14. Table 3 shows clearly that there was a very
ing urinary flow can be compared with the results of weak relationship between the perception of low flow
uroflowmetry. and objective data from uroflowmetry when patients 
were categorized above or below a Qmax of either 10
Frequency-volume charts
mL/s or 15 mL/s.
A sub-sample of 79 frequency-volume charts, selected 
randomly across all the centres, was scrutinized in detail.
Reliability
A researcher (J.D.), unaware of the results of the ICS male Internal consistency For the basic set of symptom questions
questionnaire, coded these charts according to the fre- (20 in total), and problem questions (19 in total), the
quency of urination during the day, the time between Cronbach’s alpha statistics were high, at 0 .8 4  and 0.91, 
urinations in hours, and the frequency of urination respectively. These high scores are partly a reflection of 
during the night (all as means over 7 days). These values the large number of items, but also show that these
were then coded so that they reflected the coding of the parts of the questionnaire have excellent levels of internal
ICSmale questionnaire for question 1 (frequency in times 
per day; 1 -6 ,  7 -8 , 9 -1 0 ,  1 1 -1 2 , ^  13), question 28
consistency. The Cronbach's alpha statistic for the stor­
age symptoms was 0 .6 9 , for the voiding symptoms 0.75,
(frequency in hours; hourly, 2-, 3-, 5s 4-hourly) and 
question 2 (nocturia; not at all, once, twice, three times,
and for the other symptoms 0.69. For the problem 
questions it was 0 .82  (storage), 0 .85 (voiding), and 0.75
four times or more). The wording of these questions is for the other problems.
detailed in Fig. 1. After cross-tabulation of these classifi­
cations of the frequency-volume chart against the Test-retest reliability For seven symptom questions and 
responses to the questionnaire, the proportion of individ- 11 problem questions there was excellent test-retest 
uals in the same category on both classifications was reliability, with a maximum difference of one category
calculated giving the ‘exact’ crude agreement.
The ‘exact' crude agreement between the frequency
between the time points (e.g. from ‘occasionally’ to 
‘sometimes’). For the other questions, some had larger
volume data and question 1 (frequency in times per day) discrepancies, but typically these were for only one 
was 41%, compared with agreement of 61% for question individual of the 4 0  studied. The reliability of the six
28 (frequency in hours between urinations). The ‘exact’ most common urinary symptoms and problems is
agreement for question 2 (nocturia) was 68%. The portrayed graphically in Figs 2 and 3. In Fig. 2, re-
corresponding Kappa values were 0.20, 0 .27  and 0.57, duced stream, terminal and nocturia were
respectively, indicating at best a ‘fair’ agreement for the the most reliable of the common symptom questions,
frequency questions, but better (‘moderate’ to ‘good’) with none or only one patient moving more than one
agreement for nocturia [18]. category between the time points. Incomplete emptying,
If the criteria for agreement are widened to allow a
discrepancy of plus or minus one category, these agree­
ments rise to 91% (question 1), 99% (question 28) and 
97% (question 2).
Table 3 Low flow rate on uroflowmetry (Omtir ), according to two 
different thresholds, compared with perception of reduced stream 
in ICSmale questions 12 and 14. The number of patients in each
category Is given, with the percentage of men perceiving a reduced
Uroflowmetry
Patients were asked to void into a flowmeter three times: 
47% voided three times, 36% twice and 17% once (n — 
1190). Two questions in the ICS male questionnaire 
address the issue of reduced stream (see Fig. 1).
Question 12 asked men to judge whether the strength 
of their urinary stream was ‘normal’ or ‘reduced 
occasionally’, ‘sometimes1, ‘most of the time’ or ‘all of 
the time’. Question 14  asked the men to indicate their 
flow rate on a diagram of a man urinating (4 indicating
stream as a proportion of those achieving the given How rate 
during uroflowmetry
Flow rate (Qmax) 
stream (Q14), (mL/s)
Stream reduced at Urn 
occasionally (Q12) 
(Number [%])
t Reduced stream 
(2, 3, or 4  on Q14) 
(Number [%])
< 1 0 515 (96) 529 (99)
^ 1 0 648 (92) 702 (99)
< 1 5 890 (95) 927 (99)
Ssl5 273 (88) 304 (98)
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1 During the day, how many times do you urinate, on average?
How much of a problem is this for you?
1 to 6 times 
7 to 8 times 
9 to 10 times 
11 to 12 times 
13 or more times
Not a problem 
A bit of a problem 
Quite a problem 
A serious problem
2 During the night, how many times do you have to get up to urinate, on average?
How much of a problem is this for you?
None 
One 
Two 
Three 
Four or more
Not a problem 
A bit of a problem 
Quite a problem 
A serious problem
12 Would you say that the strength of your urinary stream is.... Normal
Occasionally reduced
Sometimes reduced
Reduced most of the time
Reduced all of the time
How much of a problem Is this for you? Not a problem
A bit of a problem |
Quite a problem I
A serious problem f~
14 Please ring the number that corresponds with the strength of your urinary stream over the past 
month.
28 How often do you pass urine during the day?
How much of a problem Is this for you?
Which is it?
4 3
*«•*
\
\
\A
\
2 1
Fig. 1 Wording of selected questions and responses in the ICSmale questionnaire
From Peeling, 1989)122]
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Hourly 
Every 2 hours 
Every 3 hours 
Every 4 hours or more
Not a problem 
A bit of a problem 
Quite a problem 
A serious problem
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1996 British Journal of Urology 77, 554-562
560 J.L. DONOVAN et al
ca)
E
o
CD
X I
E3
40
30
20
10
0
Terminal dribble
I
2 -1 0 
Difference
1 2
c
CD
E
CD
X I
E3
z
40
30
20
10
0
Hesitancy
2
■I m i i
1 0 
Difference
1 2
C0)
E
o
CD
X I
E3
z
40
30
20
10
0 »«>
Intermittency
■ ' : ' : .s : t ' •
2 1 0 1 2 3
Difference
c0)
E
o
a>X3
E
z
40
30
20
10
0
Incomplete emptying
¿mm
2 1 0 
Difference
1 2
c
CD
E
o
X I
E
VMM
z
40
30
20
10
0
Nocturia
2 -1 0 
Difference
1 2
_ 40c
CD
E 30
20
o
0)JQ
E3
m pj pl
10
0
jr »•
Reduced stream
I ¿Mb Mi.*..»*;* Kh\/r’»iV-W* V: 1 J
2 1 0 
Difference
1 2
Fig. 2 Test-retest reliability of six commonest symptom questions (n =  40)
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Fig. 3 Test-retest reliability of six commonest problem questions (n = 40)
intermittency and hesitancy were less reliable, with be­
tween two and five patients moving more than one 
category. Amongst the questions about problems (Fig. 3 ), 
all except reduced stream were highly reliable.
Simple additive scores were computed for the question­
naire to assess further the test-retest reliability. The 
overall Spearman rank correlation coefficient for 
symptom score between the time points was 0 .78  (95% 
Cl, 0 .62  to 0.88); for this problem score it was 0 .83  
(95% Cl, 0 .70  to 0.91).
rnI of for validity and 
available for use in
of
has vi
widely. Little validation has been carried out in any 
formai sense for the Boyarsky or Madsen-Iversen scores.
instrument has had some validation in 
ition to changes in scores before and after treatment
issessment of validity and reliability in terms of5
ic testing (e.g. formal comparisons of urology
(D 1996 British Journal of Urology 77, 554-562
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patients and non-urology patients) has been carried out Importantly, however, there was considerably better 
on the AHA [7], DAN-PSS-1 [6] and Bolognese[9] symp- agreement between the results of the frequency-volume 
tom scores. This paper reports similar investigations for charts and the questionnaire when a slightly more
the ICSmale questionnaire.
The ICSmale questionnaire was designed to be self-
flexible approach was taken.
It is possible from these analyses to choose between
completed and the majority of ICS-BPH’ patients and the questions concerning frequency in the developmental
men in the community [10] found it easy to complete version of the ICSmale questionnaire. Specifically, ques-
in full and unaided. In-depth interviews with men carried tion 28 (frequency in hours between urinations) has a
out by one of the authors (J.D.) during the piloting of higher level of validity in relation to the frequency
the questionnaire indicated that men found the questions volume charts than does question 1 (frequency according
and response categories easily understandable. The tc
results in the present study indicate that the question- awaits the results of analyses of symptoms in relation to
number
n aire has of acceptability. National pQS (papers in preparation).
co-ordinators for the study have indicated that the 
questionnaire covers all appropriate symptoms. Overall,
The results indicate that there was very 
ship between the men’s perception of their stream being
therefore, the ICS;n«k' questionnaire has a high level of reduced and the uroflowmetry data (represented by their
content validity. highest flow). There may be several reasons for this, e.g.
The ICSmale questionnaire detected the expected posi- the men’s normal experience of flow may not be repro
tive age gradient for the majority of urinary symptoms duced by the artificiality of voiding into a flowmeter in 
in the community sample. The symptoms showing the a clinical setting. It may also be that the men’s reporting
strongest positive relationships with age in the com­
munity sample (nocturia and urge incontinence) were
of their flow rate is most likely to be based only their 
own experience of their flow rate, and so the perception
also positively related to age in the ICS-BPH’ patients. 
In part, the increasing prevalence of nocturia reflects the
of what is normal and abnormal is probably quite 
variable between individuals and not necessarily related
increasing occurrence of nocturnal polyuria secondary 
to covert cardiac failure [21], whereas the increase in
to what is measured on uroflowmetry. Clearly, a man 
who has previously had a very high flow rate may
urge incontinence is probably due to the strong relation- perceive it to be reduced, but it may remain more than
ship between detrusor instability and age [8]. The 15 mL/s. It may also be that the wording of question
relationships of other symptoms with age for the 12 and the figure in question 14 do not manage to
ICS-BPH’ patients are either non-existent or even nega- capture accurately the men’s perceptions of their flow
tive. This is likely to be largely because the patient group rate. It is clear that neither of these questions in their
is self-selecting according to the level of symptoms. present form relates closely to free-flow rates. It is also
The ICSmale questionnaire was able to differentiate the case that the patient may be assessing the whole of
clearly between men in the community and a sample micturition, not just the Qmax from the uroflowmetry
derived from a clinical population. Higher levels of considered in this analysis.
symptoms were evident in the ICS-BPH’ patients and, The internal consistency (as measured by Cronbach’s
amongst those with symptoms, the ICS-BPH’ patients alpha) of the ICS male questionnaire was very high. The
considered them to be bothersome much more frequently values given are very similar to those reported for the
than those in the community sample [10]. In combi- AUA score overall and for storage and voiding symptoms
nation with the results concerning age, this suggests [7]. The results for the ICS male questionnaire also indi-
that
Ve
questionnaire has good construct cate that internal consistency is not i
the questionnaire into the « ;rary
The poor exact agreement between the data from the storage and voiding symptoms.
frequency-volume charts and the questions on urinary It is particularly important that a questionnaire
frequency and nocturia has a variety of possible expla- to be used for assessing outcome is stable at bi
nations. It is perhaps unreasonable to expect an unpre- otherwise it will be difficult to interpret changes
pared patient to categorize their urinary frequency an intervention. This was assessed for the ICSmale ques
accurately and within the constraints of a questionnaire. tionnaire by a test-retest analysis. Given the high corre-
Further, in the frequency-volume charts studied, many lations of scores and, more pertinently, the high
patients reported different levels of frequency from day proportions of men with the same symptom assignments
to day, thus adding to the difficulty in specification. It is on both occasions, the results indicate that the ICSmale
also possible that patients’ experiences over the questionnaire is highly reliable.
previous day or two will influence their report or that In conclusion, has high
symptoms levels of psychometric validity and reliability. It is now
© 1996 British Journal of Urology 77, 554-562
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possible and necessary to examine the relationships 
between responses to this wide-ranging questionnaire 
and the results of pressure-llow studies.
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